Top compounds associated with response to LINC01125


Feature Type Standardized
Nominal ANOVA
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.053 0.1
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC 0.055 0.1
mRNA quizartinib CTRPv2 pan-cancer AAC 0.06 0.1
mRNA TPCA-1 CTRPv2 pan-cancer AAC -0.052 0.1
mRNA BRD-K63431240 CTRPv2 pan-cancer AAC -0.057 0.1
mRNA BRD9876 CTRPv2 pan-cancer AAC 0.061 0.1
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.055 0.1
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC 0.061 0.1
mRNA SJ-172550 CTRPv2 pan-cancer AAC 0.06 0.1
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.054 0.1
Download CSV